反应详情

Following the general procedure of EXAMPLE 204, Part B), and making non-critical variations but substituting 1-benzyl-4-[N-ethyl-N-(3-nitro-2-pyridinyl)amino]piperidine (EXAMPLE 204, Part A) for 1-benzyl-4-[N-propyl-N-(3-nitro-2-pyridinyl)amino]piperidine, the title compound is obtained, NMR (CDCl3) 7.84, 7.31, 7.26, 6.96, 6.85, 3.97, 3.50, 3.18, 3.07, 2.89, 2.02, 1.75 and 0.89δ.